SlidesetHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #1 Comparable Dynamics of Cell-Associated HIV-RNA, Total and Intact Proviral HIV-1 DNA in Virologically Suppressed People with HIV Switching to 2DR or Continuing 3DR Over an 18-Month Follow-Up - Lia FiaschiView Slideset
JAJuan AmbrosioniMD, PhDVideoHIV23rd European Meeting on HIV & Hepatitis 2025Efficacy, Toxicity and Adherence Considerations - Juan AmbrosioniView Video
JAJuan AmbrosioniMD, PhDSlidesetHIV23rd European Meeting on HIV & Hepatitis 2025Efficacy, Toxicity and Adherence Considerations - Juan AmbrosioniView Slideset
FCFrancesca Ceccherini-SilbersteinPhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-1923rd European Meeting on HIV & Hepatitis 2025How to Improve Fruitful Dialogue between the Virology Lab and Clinicians (Lab Manager Perspective) - Francesca Ceccherini SilbersteinView Slideset
Poster17th International Workshop on Pediatrics & HIV 2025(E-Poster) #22 Causes of Death among Sub-Saharan African Infants Living with HIV and Hospitalised with Severe Pneumonia Using Minimally Invasive Autopsies in the EMPIRICAL TrialView Poster
Poster17th International Workshop on Pediatrics & HIV 2025(E-Poster) #20 Telomere Length and Neurodevelopmental Outcomes among Children Exposed and Not Exposed to HIV in KenyaView Poster
Abstract2nd Conference on Innovations in Tuberculosis 2025(Abstract) #17 Economic Recovery Among Patients Following Drug-Susceptible Tuberculosis Treatment in Johannesburg, South AfricaView Abstract
JDJohn DitekemenaMD, MPH, PhDVideoTuberculosis2nd Conference on Innovations in Tuberculosis 2025Towards Integrated Prevention, Treatment, and Service Provision for TB, HIV and NCDs - John DitekemenaView Video
JDJohn DitekemenaMD, MPH, PhDSlidesetTuberculosis2nd Conference on Innovations in Tuberculosis 2025Towards Integrated Prevention, Treatment, and Service Provision for TB, HIV and NCDs - John DitekemenaView Slideset
BdJBouke de JongMSc, PhDVideoTuberculosis2nd Conference on Innovations in Tuberculosis 2025Should Africa Move to Whole Genome Sequencing for Drug Resistance Testing? Con Standpoint - Bouke de JongView Video
BdJBouke de JongMSc, PhDSlidesetTuberculosis2nd Conference on Innovations in Tuberculosis 2025Should Africa Move to Whole Genome Sequencing for Drug Resistance Testing? Con Standpoint - Bouke de Jong View Slideset
VideoTuberculosis2nd Conference on Innovations in Tuberculosis 2025Abstract #17 Economic Recovery Among Patients Following Drug-Susceptible Tuberculosis Treatment in Johannesburg, South Africa - Kamban HirasenView Video
